Showing posts with label Vector Borne Diseases. Show all posts
Showing posts with label Vector Borne Diseases. Show all posts

The Risks Of Chikungunya Outbreaks In The United States

 

image

Credit Wikipedia


# 6855

 

 

Chikungunya, up until about a decade ago, was a little known mosquito-borne disease first described in Tanganyika in the early 1950s. For the next five decades it was sporadically seen across eastern and central Africa.

 

That is, until 2005, when Chikungunya made a surprise jump to the Indian Ocean island of Réunion. There, it infected nearly 1/3rd of the island’s 770,000 residents (see 2006 EID article Chikungunya Disease Outbreak, Reunion Island) in just a matter of months.

 

Chikungunya typically produces a fever, severe muscle and joint pain, and headaches. The symptoms usually go away after a few weeks, but some patients can sustain permanent disability, and some deaths have been reported.

 

In the eight years since that  jump, `Chik’ has spread further across the Indian Ocean, Southeast Asia, and even briefly into northern Italy.

 

While the virus isn't normally found in Europe, the vector, the Aedes mosquito, is.  All it took was one infected traveler to arrive infected with the virus to start the chain of transmission.

 

image

 

I told the story several years ago in It's A Smaller World After All, but the short version is that a traveler, returning from India, brought the virus to Italy in 2007 which led to more than 290 cases reported in the province of Ravenna, which is in northeast Italy.

 

The concern is that the same sort of introduction could happen elsewhere in Europe, or here in the United States, just as we saw with West Nile Virus in 1999 (see DVBID: Final West Nile Report For 2012) and with Dengue Fever in 2010 (see MMWR: Dengue Fever In Key West)

 

The two primary mosquito vectors of Chikungunya are the Aedes aegypti and Aedes albopictus (cite WHO FAQ) both of which can be found across many regions of the Americas.

image

Aedes albopictus (Asian Tiger) Mosquito - Wikipedia

Dark blue: Native range
Dark green: introduced (as of December 2007)

 

The risk is considered great enough that early last year, the CDC and PAHO (Pan American Health Organization) put together a 161-page guide on preparing for the arrival of Chikungunya to the Americas (see Preparedness and Response for Chikungunya Virus Introduction in the Americas).

 

All of which serves as prelude to a report that appeared last month in PloS Neglected Tropical Diseases called:

 

Modeling Dynamic Introduction of Chikungunya Virus in the United States

Abstract (reparagraphed for readability)

Chikungunya is a mosquito-borne viral infection of humans that previously was confined to regions in central Africa. However, during this century, the virus has shown surprising potential for geographic expansion as it invaded other countries including more temperate regions.

 

With no vaccine and no specific treatment, the main control strategy for Chikungunya remains preventive control of mosquito populations. In consideration for the risk of Chikungunya introduction to the US, we developed a model for disease introduction based on virus introduction by one individual. Our study combines a climate-based mosquito population dynamics stochastic model with an epidemiological model to identify temporal windows that have epidemic risk. We ran this model with temperature data from different locations to study the geographic sensitivity of epidemic potential.

 

We found that in locations with marked seasonal variation in temperature there also was a season of epidemic risk matching the period of the year in which mosquito populations survive and grow. In these locations controlling mosquito population sizes might be an efficient strategy.

 

But, in other locations where the temperature supports mosquito development all year the epidemic risk is high and (practically) constant. In these locations, mosquito population control alone might not be an efficient disease control strategy and other approaches should be implemented to complement it.

 

Our results strongly suggest that, in the event of an introduction and establishment of Chikungunya in the US, endemic and epidemic regions would emerge initially, primarily defined by environmental factors controlling annual mosquito population cycles. These regions should be identified to plan different intervention measures.

In addition, reducing vector: human ratios can lower the probability and magnitude of outbreaks for regions with strong seasonal temperature patterns. This is the first model to consider Chikungunya risk in the US and can be applied to other vector borne diseases.

(Continue . . . )

 


More background on this modeling study is available from the Cornell University Press Office.

 

 

Chances seen rising for chikungunya outbreaks in NYC, Atlanta, Miami

ITHACA, N.Y. – Global travel and climate warming could be creating the right conditions for outbreaks of a new virus in this country, according to a new Cornell University computer model.

 

The model predicts that outbreaks of chikungunya, a painful virus transported by travelers and spread by the invasive Asian tiger mosquito, could occur in 2013 in New York City during August and September, in Atlanta from June through September, and year-round in Miami. The probability of a disease outbreak is correlated with temperature, as warmer weather allows the Asian tiger mosquito to breed faster and grow in numbers, according to the study published in the November issue of PLOS Neglected Tropical Diseases.

 

According to the simulation, there is a high probability of a chikungunya outbreak if a single infected person arrives in New York in July or August and is bitten by an Asian tiger mosquito. The risks are the same, but with wider time frames, for transmission in Atlanta and Miami, according to the paper.

 

Asian tiger mosquitoes were introduced to the United States in Texas in the 1980s; they are established up the East Coast into New Jersey and are rising in numbers in New York City. The aggressive mosquito outcompetes local varieties and transmits more than 20 pathogens, including chikungunya and dengue, said Laura Harrington, associate professor of entomology and the study’s senior author.

 

“The virus is moving in people, and resident mosquito populations are picking it up,” Harrington said.

 

The model estimates that with typical regional temperatures, a chikungunya outbreak in New York would infect about one in 5,000 people, said Diego Ruiz-Moreno, a postdoctoral associate and the paper’s lead author

 

“However, this number would increase drastically as temperatures rise due to climate change,” Ruiz-Moreno said.

(Continue . . . )

 

While this study focused on Chikungunya, much the same could be said about the potential for seeing Dengue, Malaria, or even Yellow Fever making inroads in the United States and Europe. 

 

In March of 2010 the journal  Eurosurveillance carried a series of articles on vector borne diseases and their potential to impact those living in Europe. One of the articles, Yellow fever and dengue: a threat to Europe? by P. Reiter, had these sobering comments about the future of vector-borne illnesses in Europe.

 

The history of dengue and yellow fever in Europe is evidence that conditions are already suitable for transmission. The establishment of Ae. albopictus has made this possible, and the possibility will increase as the species expands northwards, or if Ae. aegypti is re-established.

 

The epidemic of chikungunya in northern Italy in 2007 [8,49] confirms that Ae. albopictus is capable of supporting epidemic transmission, although laboratory studies indicate that the strain of virus involved was particularly adapted to this species [50,51].

 

Nevertheless, it is not unreasonable to assume that climatic conditions that permit malaria transmission will also support transmission of yellow fever and dengue, in which case transmission could extend into northern Europe [52].

 

Reason enough that if you live in - or are visiting  - a mosquito prone area, to remember to follow the `5 D’s’  (courtesy Florida Department of Health).

 

image

»» Read More

DVBID: Final West Nile Report For 2012

image

 

# 6779

 

While final numbers won’t be available until the spring, 2012 looks like it will go down as one of the most active West Nile Fever seasons since the virus arrived in North America in 1999.

 

The CDC’s  DVBID has released their final tally of cases for 2012 on their West Nile Update Page.  They summarize the season thusly:

 

2012 West Nile virus update: December 11

This will be the last update for 2012 until final data are available in the spring of 2013.

As of December 11, 2012, 48 states have reported West Nile virus infections in people, birds, or mosquitoes. A total of 5,387 cases of West Nile virus disease in people, including 243 deaths, have been reported to CDC. Of these, 2,734 (51%) were classified as neuroinvasive disease (such as meningitis or encephalitis) and 2,653 (49%) were classified as non-neuroinvasive disease.

 

The 5,387 cases reported thus far in 2012 is the highest number of West Nile virus disease cases reported to CDC through the second week in December since 2003. Eighty percent of the cases have been reported from 13 states (Texas, California, Louisiana, Illinois, Mississippi, South Dakota, Michigan, Oklahoma, Nebraska, Colorado, Arizona, Ohio, and New York) and a third of all cases have been reported from Texas.

 

Neuroinvasive cases (which present with meningitis, encephalitis, or flaccid Paralysis) are severe enough that they result in hospitalization and diagnosis, and so they are considered the best indicator of the scope of each year’s epidemic.

 

Mild cases – called West Nile Fever – often go undiagnosed, with probably only 2%-3% being identified.

 

Meaning that with more than 2,600 mild cases reported, the true incidence was probably in excess of 100,000 infections.


Hardest hit this year was Texas, with more than 1,700 cases and 76 deaths. Far behind, but in second place, was California with 461 cases and 16 deaths. 

 

Nevertheless, the highest incidence of neuroinvasive disease occurred along the Gulf Coast and into the upper Mid West.

 

image

 

Earlier this year the CDC indicated they would be taking a look at this year’s WNV season to see if any changes have occurred in the virus to account for this sudden spike in activity. 

 

While West Nile season has passed for most of the country, there are still a few areas where mosquitoes are still active.  So, if you live in, or are visiting one of these areas, the advice by many health departments to follow the `5 D’s’ remains intact. 

image

»» Read More

DVBID: West Nile Infections Continue Record Pace

image

Credit DVBID


# 6604

 

The DVBID (Division of Vector Borne Infectious Diseases) has updated their West Nile numbers as reported to them through October 2nd, and as expected the number of new cases, and deaths, continues to rise.

 

2012 West Nile virus update: October 2

As of October 2, 2012, 48 states have reported West Nile virus infections in people, birds, or mosquitoes. A total of 3,969 cases of West Nile virus disease in people, including 163 deaths, have been reported to CDC. Of these, 2,010 (51%) were classified as neuroinvasive disease (such as meningitis or encephalitis) and 1,959 (49%) were classified as non-neuroinvasive disease.

 

The 3,969 cases reported thus far in 2012 is the highest number of West Nile virus disease cases reported to CDC through the first week in October since 2003. Almost 70 percent of the cases have been reported from eight states (Texas, California, Louisiana, Mississippi, South Dakota, Michigan, Oklahoma, and Illinois) and a third of all cases have been reported from Texas.

 

The record pace continues, and we can expect – given incubation period of 2 or 3 weeks, and since some people may succumb only after weeks of illness – that we will see these numbers continue to rise for the next couple of months.

 

 

The incidence level of the more serious neuroinvasive form of West Nile disease – which can produce encephalitis, meningitis, and/or acute flaccid paralysis – is illustrated by the following chart. 

 

image

 

Although the peak period of transmission for WNV may have passed, infected mosquitoes are still out there and are still biting and infecting people.

 

So we still need to heed the advice of our local health departments to  follow the `5 D’s’ of mosquito protection:

image

 

And finally, to find out about the West Nile threat in your area, you can visit the DVBID website below:

Links to State and Local Government West Nile Virus Web Sites

 

Click on a state to link directly to their West Nile virus Web page.

See list below for additional city-level and main State Health Department Web sites.

Image: West Nile Virus Map of States with links to their West Nile Virus pages

»» Read More

DVBID Update On West Nile Virus

 

image

Source DVBID

 

# 6586

 


While the big infectious disease news this week has been the novel coronavirus that has killed one Saudi, and seriously sickened a Qatari man, there are other infectious disease threats we follow, including West Nile Disease.

 

The DVBID has updated their West Nile website, and while the number of new infections is beginning to decline, 13 additional deaths have been reported via ArboNet in the last week.

 

 

2012 West Nile virus update: September 25

As of September 25, 2012, 48 states have reported West Nile virus infections in people, birds, or mosquitoes. A total of 3,545 cases of West Nile virus disease in people, including 147 deaths, have been reported to CDC. Of these, 1,816 (51%) were classified as neuroinvasive disease (such as meningitis or encephalitis) and 1,729 (49%) were classified as non-neuroinvasive disease.

 

The 3,545 cases reported thus far in 2012 is the highest number of West Nile virus disease cases reported to CDC through the last week in September since 2003. Seventy percent of the cases have been reported from eight states (Texas, Mississippi, South Dakota, Michigan, California, Louisiana, Oklahoma, and Illinois) and 38 percent of all cases have been reported from Texas.

 

It should be noted that the latest numbers reported via ArboNet may lag behind the most recent totals being reported by each state.  

 

Case in point: Texas,  which is shown to have  1345 cases and 52 deaths in today’s report, is reporting somewhat higher numbers on their website:

 

image

The incidence level of the more serious neuroinvasive form of West Nile disease – which can produce encephalitis, meningitis, and/or acute flaccid paralysis – is illustrated by the following chart. 

 

image 

 

Although the peak period of transmission for WNV may have passed, infected mosquitoes are still out there and are still biting and infecting people.

 

So we still need to heed the advice of our local health departments to  follow the `5 D’s’ of mosquito protection:

image

»» Read More

CDC West Nile Update

 

image

Credit DVBID

 

 

# 6539

 

I was away from my desk yesterday for the CDC’s  teleconference update on West Nile activity across the nation, but Lisa Schnirring for CIDRAP News  has an excellent overview.   

 

West Nile virus cases continue record pace

Lisa Schnirring * Staff Writer

Sep 5, 2012 (CIDRAP News) – The number of West Nile virus cases in the United States this year has jumped by about 25% in the past week, and though new reports are still coming in at a record pace, Texas—the hardest hit state—is seeing some promising signs that interventions such as aerial spraying are working.

(Continue . . .)

 


The transcript of this teleconference and an audio file is now available on the CDC Newsroom webpage.

image

 

Texas, which has been particularly hard hit this year, has now reported 40 deaths, and a record 495 neuroinvasive cases this year.

 

Neuroinvasive cases (which present with meningitis, encephalitis, or flaccid Paralysis) are severe enough that they result in hospitalization and diagnosis, and so they are considered a better indicator of the scope of each year’s epidemic.

 

Mild cases – called West Nile Fever – often go undiagnosed, with probably only 2%-3% being identified.

 

As you can see from the chart below, while 44 states have reported human infections with the West Nile Virus this year, it is the middle of the country that is being hardest hit by neuroinvasive WNV.

 

image

Credit DVBID

 

Vector-borne illnesses like West Nile Virus, EEE (Eastern Equine Encephalitis), Dengue, Lyme Disease, Babesia, Powassan Virus, and even the newly reported Heartland Virus (see also Maryn McKenna’s report) are becoming increasingly common across the United States.

 

Many scientists believe that as climate change occurs, we will see more of these mosquito, flea, tick, and biting fly transmitted diseases here, and in the European Union.

 

To give you an idea how quickly a new, vector-borne disease like West Nile can spread, the WNV only arrived in the United States twelve years ago and in a few short few years had invaded all 48 contiguous states.

 

From the USGS Factsheet on West Nile Virus

image

 

Prevention is the key.

 

West Nile Virus is now endemic across most of the United States and the prudent move is to take the recommended precautions against mosquito bites.

 

 

image

 

And ticks, which can also easily transmit diseases, require preventative measures as well.

image

(Credit CDC)

 

image

»» Read More

CDC Telebriefing on West Nile Virus

 

image

 

# 6510

 


A public health situation we’ve been following here for the past several weeks (see here, here, here, and here) was the subject of a CDC telebriefing today; the unusually high incidence of West Nile infections across the country, but most noticeably in Texas.

 

According to the CDC’s Dr. Lyle R. Petersen, director of the DVBID at the CDC, 2012 may be on track to be the worst yet in the 13 year history of the virus in the United States.

 

Yesterday, the CDC’s DVBID division updated their numbers through August 21st, indicating:

 

2012 West Nile virus update: as of August 21

Thus far in 2012, 47 states have reported West Nile virus infections in people, birds, or mosquitoes. A total of 1118 cases of West Nile virus disease in people, including 41 deaths, have been reported to CDC. Of these, 629 (56%) were classified as neuroinvasive disease (such as meningitis or encephalitis) and 489 (44%) were classified as non-neuroinvasive disease.

 

The 1118 cases reported thus far in 2012 is the highest number of West Nile virus disease cases reported to CDC through the third week in August since West Nile virus was first detected in the United States in 1999. Approximately 75 percent of the cases have been reported from 5 states (Texas, Mississippi, Louisiana, South Dakota, and Oklahoma) and almost half of all cases have been reported from Texas.

 

 

Of the 1118 cases, nearly half (n=537) are from Texas, and 26 deaths so far this year have been recorded in the Lone Star State. Hard hit Dallas county reported their 11th fatality yesterday.

 

Elsewhere across the nation, 38 other states have reported West Nile infections in humans, and deaths have been reported across 16 states.

 

Of note, Louisiana has reported 6 fatalities and Oklahoma has reported 3.

 


Today’s telebriefing featured Lyle R. Petersen, M.D. and the transcript should be posted on the CDC’s media site tonight or tomorrow (now available at this link).

 

Lisa Schnirring writing for CIDRAP NEWS has an excellent summary of today’s briefing:

 

CDC reports surge in US West Nile virus activity

Lisa Schnirring * Staff Writer

Aug 22, 2012 (CIDRAP News) – The United States is experiencing a dramatic rise in the cases of West Nile virus (WNV) infections over the past month, with record-setting numbers expected over the next several weeks and the US Centers for Disease Control and Prevention (CDC) warning people to take key preventive steps.

 

So far, 38 states have reported human cases, but the epicenter is Texas, which has reported half of the WNV infections. The CDC said so far it has received reports of 1,118 cases, including 629 people with the neuroinvasive form of the disease. Nationally, 41 deaths have been reported.

(Continue . . .)

 

 

 

Given that the WNV season doesn’t usually peak until mid-August, and it can take 2 to 3 weeks for symptoms to develop, many more cases are expected over the next few months.

 

While 80% of those infected don’t show symptoms, last week WEBMD carried a report (see New West Nile Threat: Kidney Disease) about research conducted by Baylor University West Nile expert Kristy O. Murray, PhD, DVM.

 

Dr. Murray’s research (see Persistent Infection with West Nile Virus Years after Initial Infection) suggests long-term sequelae may develop among a significant percentage of those who are infected with the West Nile Virus – even among those infected asymptomatically.

 

Dr. Murray was awarded an NIH grant in 2011 to study the effects of chronic WNV infection on the kidneys and central nervous system.

 

Reason enough to take seriously the recommendations from health departments across the nation that urge people to follow the `5 D’s’ of mosquito protection:

image

To find out about the West Nile threat in your area, you can visit the DVBID website below:

Links to State and Local Government West Nile Virus Web Sites

 Image: West Nile Virus Map of States with links to their West Nile Virus pages

And as a final note, the CDC recently updated their information on mosquito repellants.

Updated Information regarding Insect Repellents

»» Read More

EEE: Eastern Equine Encephalitis

 

image

# 6501

 

While West Nile Virus is making headlines in Texas and across much of the nation, another mosquito-borne virus – EEE (Eastern Equine Encephalitis) – has the attention of Massachusetts health officials.

 

On Thursday, the Massachusetts Department of Health & Human Services released the following alert:

 

State Health Officials Raise EEE Threat Level in Two Communities after Detection of EEE-Positive Mosquitoes

New Bedford and Westborough raised to High; ground spraying to be enhanced

BOSTON — Thursday, August 16, 2012 – The Massachusetts Department of Public Health (DPH) today announced the detection of mammal-biting mosquitoes infected with Eastern Equine Encephalitis (EEE) in New Bedford and Westborough. As a result, health officials have raised the EEE threat level to “High” in these two communities and recommend that outdoor evening events are curtailed there for the remainder of the summer. Ground-based spraying by mosquito control projects is ongoing in both New Bedford and Westborough and will be enhanced.

(Continue. . . )

 

 

So far, only one human case of EEE has been detected in Massachusetts this year, and that one is believed to have been acquired out of state. This risk of seeing additional cases, however, is deemed high in communities where human-biting mosquitoes are found to carry the virus.

 

Although far less common than West Nile Virus, EEE is of concern because it has a high fatality rate (35%), and among the survivors, a large number suffer ongoing neurological problems.

 

Over the past decade there have been an average of about 7 cases (not deaths) of `Triple E’ in the United States each year (range range: 3—21), which makes EEE an exceedingly rare disease in humans.

 

But given its severity (and the co-circulation of other mosquito borne diseases like West Nile, La Cross Virus, & SLEV), it makes sense to take steps to protect against mosquito bites – even if your local officials have not issued a warning.

 

The Florida Department of Health’s advice to protect  against mosquito borne diseases is that people should practice the "5 D's"

Don't go outdoors at DUSK and DAWN when mosquitoes are most active.

DRESS so your skin is covered with clothing

Apply mosquito repellent containing DEET to bare skin and clothing. 

Other effective repellents include picaridin, oil of lemon eucalyptus, and IR3535

Empty containers and DRAIN standing water around your home where mosquitoes can lay eggs.

 

 

While the number of yearly cases is low, the distribution of EEE in the United States far ranging.

image

 

The natural host for the EEE virus are songbirds, which can become infected usually without suffering ill effect.  The virus is spread among these birds by the blood feeding of female mosquitoes (males don’t bite).

 

After an infected mosquito feeds on a bird, the bird becomes infected and the virus begins reproducing. After a few days, and for only a few days, the bird’s bloodstream amplifies the virus enough to infect subsequent mosquitoes that feed on it.

 

Culiseta melanura, which means "curly black hairs", is the species of swamp mosquito that serves as the primary vector for this virus among birds.

image 

Culiseta melanura, however, isn’t usually attracted to humans.

 

So it generally requires a secondary type of mosquito - one that isn’t quite as picky a feeder - such as the Aedes albopictus or  Coquillettidia perturbans  `salt and pepper’ mosquito, to bite an infected bird in order to move it into the equine or human population.

 

The Transmission cycle is illustrated by the following graphic from the CDC.

image

 

Humans and horses don’t develop a high enough viral EEE titer in their bloodstream to pass on the virus if they are subsequently bitten by a mosquito, so they are considered to be `dead-end hosts’.

 

 

As there is no vaccine against EEE, the best tactic is prevention, and high in that category is the use of mosquito repellants.

 

To help you with choosing the right repellant the EPA has developed an interactive insect repellant search engine that will that will allow you to input your needs and it will spit out the best repellants to use.

 

image

(click image to go to search engine)

 

 

For more on Arboviruses in the United States you may wish to revisit this blog from last year:

 

MMWR: Arboviral Disease Surveillance – 2010
»» Read More

Dallas West Nile Update

 

 image


# 6483

 


While we await today’s MMWR and a briefing this afternoon from the CDC on the H3N2v outbreak in Ohio and Indiana, we’ve three more West Nile Virus (WNV) deaths to report in Dallas County, Texas this week (see Ninth West Nile Virus Related Death in Dallas County August 8, 2012). 

 

Nationally, as of August 7th, 253 neuroinvasive cases of WNV have been reported to ArboNET, along with 137 non-neuroinvasive WNV infections. 

 

Of those, roughly half have been reported out of the state of Texas (see CHART).

 

 

It is estimated that only about 20% of the people who are infected with WNV develop symptoms, and the vast majority of those only experience a mild flu-like illness. Accordingly, mild, asymptomatic, or non-neuroinvasive infections are likely vastly undercounted.

 

The more severe `neuroinvasive’ form of WNV can produce symptoms that include headache, stiff neck, confusion, coma, convulsions, and even paralysis.

 

According to the CDC’s  WEST NILE SYMPTOMS Q&A page.

 

It is estimated that approximately 1 in 150 persons infected with the West Nile virus will develop a more severe form of disease. Serious illness can occur in people of any age, however people over age 50 and some immunocompromised persons (for example, transplant patients) are at the highest risk for getting severely ill when infected with WNV.

<SNIP>

When someone is infected with West Nile virus (WNV) they will typically have one of three outcomes: No symptoms (most likely), West Nile fever (WNF in about 20% of people) or severe West Nile disease, such as meningitis or encephalitis (less than 1% of those who get infected).

If you develop a high fever with severe headache, consult your health care provider.

 

While many are concerned this week over an emerging swine flu virus, so far we are not aware of any deaths or serious illness from that flu strain.

 

The same, sadly, cannot be said about mosquito borne illnesses this summer. 

 

Reason enough for health departments across the nation to urge people to follow the `5 D’s’ of mosquito protection:

image

To find out about the West Nile threat in your area, you can visit the DVBID website below:

 
Links to State and Local Government West Nile Virus Web Sites

Click on a state to link directly to their West Nile virus Web page.

See list below for additional city-level and main State Health Department Web sites.

Image: West Nile Virus Map of States with links to their West Nile Virus pages

»» Read More

ECDC: Climatic Suitability For Dengue Transmission in Europe

 

image

Credit ECDC

 


# 6452 

 

In 2007 Chikungunya made headlines as it spread rapidly across the Indian Ocean, hitting Reunion Island particularly hard.  A tropical disease - Chikungunya is spread by the bite of Aedes mosquitoes  - and until recently was found only in Africa and parts of the Indian Ocean.

 

So the unexpected outbreak of Chikungunya in September of 2007 in Northern Italy took many by surprise. 

 

I told the story in It's A Smaller World After All, but briefly: a traveler returning from India brought the virus back to the northeast Italian province of Ravenna, and before the outbreak had run its course, more than 290 people were infected.

 

This importation and subsequent spread of a rare tropical disease was a bit of a wake up call for Europe, and since then we’ve seen a good deal of study and concerns on the future of vector-borne diseases across Europe.

 

In 2010 the journal Eurosurveillance devoted an entire issue to The Threat Of Vector Borne Diseases, with perhaps the biggest threat outlined in Yellow fever and dengue: a threat to Europe? by P Reiter (excerpt below).

 

The history of dengue and yellow fever in Europe is evidence that conditions are already suitable for transmission. The establishment of Ae. albopictus has made this possible, and the possibility will increase as the species expands northwards, or if Ae. aegypti is re-established.

 

Last year in ECDC: Local Malaria Acquisition In Greece we saw more reasons for concern in the return of a scourge that had – due to diligent mosquito control measures over the past 50 years – been all but eliminated across Europe.

 

As global climate change occurs, and as mosquito species are spread inadvertently through the movement of trade goods, ships, and airplanes, the potential of new – potentially invasive – mosquito species setting up shop in Europe increases.

 

Which was the subject of an ECDC Review of status and public health importance of invasive mosquitoes in Europe last April.

 

While Malaria and Yellow Fever are of concern, the big worry has been the rapid global spread of Dengue fever over the past couple of decades might soon reach into Europe.

 

This explosive growth of Dengue around the world is well illustrated by the following graph from the World Health Organization.

 

Average annual number of dengue cases reported to the World Health Organization - has steadily increased since the 1950s, with 908 cases average reported between 1950 and 1959 and 968,564 cases average reported annually between 2000 and 2007.

What this graph doesn’t indicate is another doubling of dengue cases has taken place over the past 5 years.

 

All of which serves as prelude to  a 27-page technical report published by the ECDC today on the potential of Dengue Fever getting a foothold in continental Europe.

 

Below you’ll find the summary, and a link to the report.

 

ECDC report: Low risk of dengue transmission in Europe, while some areas climatically suitable

26 Jul 2012

ECDC

Europe appears to be at little risk from dengue transmission in comparison with other global locations, even though climatic conditions exist in some parts, new ECDC report concludes.

 

The report, entitledClimatic suitability for dengue transmission in continental Europe, summarises the key findings of a project, which developed a series of risk maps demonstrating the current and potential distribution of dengue in continental Europe.

 

The maps explore the geographical distribution and the climate suitability of dengue and the dengue mosquito vectors - Aedes aegyptiand Aedes albopictus - in Europe to assess which areas could be most suitable for dengue transmission.

 

The current risk to Europe appears to be minimal, yet some areas are more climatically suitable than others. However, the report provides a relative but not absolute calculation of the risk of dengue transmission.

 

Much of central and Mediterranean Europe is climatically suitable for Aedes albopictus, states the report; the VBORNET maps on current known distribution of Aedes albopictus show that this mosquito species is already present in many places in Mediterranean Europe. In addition, some areas could potentially be a suitable habitat for Aedes aegypti (the Mediterranean areas of Spain, France and Italy, south-eastern Europe).

 

The climatic suitability maps can be used as a tool for public health planning. A sensible strategy is to continue to monitor the spread of dengue mosquito vectors in Europeand expand vector surveillance in areas climatically suitable for these vectors.

In 2012 ECDC will produce guidelines to assist the Member States to implement invasive mosquito vector surveillance and improve coverage and harmonisation of data collection within the EU.

 

Technical report ‘Climatic suitability for dengue transmission in continental Europe‘

 

While the current risk of Dengue spread in Europe is considered minimal, the executive summary’s conclusion cautions that:

 

Suitability maps can be a useful tool for public health planning, but there are many potential sources of error that need to be properly understood.

 

The current risk to Europe from the transmission of dengue appears to be minimal, yet some areas of Europe are more suitable for transmission than others.

 

A sensible strategy is to continue to monitor the spread of Ae. albopictus across Europe, to maintain vigilance for Ae. aegypti, and to consider expanding vector surveillance in areas particularly suitable for these vectors.

 

Additional research is needed to better understand the ecology of dengue in a European context, and to assess the possible impacts of climate change and other important drivers of dengue on the risk of dengue in Europe.

 

 

For additional background on a variety of vector-borne diseases in Europe, and around the world, you may wish to revisit these earlier blogs.

 

A Pathogen That Still Plagues Mankind

ECDC: Mapping Disease Vectors

tick . . . tick . . . tick . . .

Tracking West Nile Virus In Europe

Borne In The USA

EID Journal:Vector-Borne Infections

»» Read More

ECDC: Mapping Disease Vectors

 

 

# 6332

 

 

While unlikely to gladden the hearts of travel agents around the globe, the ECDC, through the European Network for Arthropod Vector Surveillance for Human Public Health (VBORNET), has released a new set of maps showing the prevalence of various tick species in Europe.

 

These maps, along with similar maps generated for exotic and invasive mosquitoes and for Plebotomine sandflies, gain new importance as the threat of vector-borne illnesses increase across Europe.

 

First the release information and links to the maps, and then I’ll return with more on the growing threat of arthropod carried diseases in Europe.

 

ECDC launches maps on the distribution of tick species in Europe

17 May 2012

ECDC

ECDC, through the VBORNET network, publishes regularly on its website maps on exotic mosquitoes and on phlebetomines  - to provide the ECDC stakeholders and the general public with the most updated information on vector distribution. The maps are updated and improved quarterly.

 

For the first time maps on the distribution of tick species are presented, covering four tick species: Dermacentor reticulates, Hyalomma marginatum, Ixodes persulcatus, Ixodes ricinus. Another improvement is that from now on the maps on phlebotomines are provided at a finer level of geographical detail:  at the administrative level NUTS3 instead of NUTS1 level.

 

The vector distribution maps are the outcome of collaborative work of the VBORNET network and are based on collecting existing data by the network members. VBORNET is a network of medical entomologists and public health experts, funded by the European Centre for Disease Prevention and Control (ECDC).

 

ECDC, through the VBORNET network, continues to  improve the data collection for the maps: the VBORNET network is therefore looking for vector-borne disease experts who are interested in data sharing and networking (experts can contact VBORNET at vbornet@ecdc.europa.eu).

See and download latest maps on vector distribution (updated 16 May 2012):
VBORNET maps – Tick species
VBORNET maps - Mosquitoes
VBORNET maps – Phlebotomines/Sandflies

 

 

In Europe ticks are known to carry and transmit a variety of diseases, including Crimean Congo hemorrhagic fever, Borreliosis, Tick-borne encephalitis, Tick-borne relapsing fever, Tularaemia, and Rickettsios.

 

And with changes in the climate, the range of ticks and the pattern of disease spread is likely to evolve over time.

 

The ECDC provides communication toolkits, designed for a variety of recipients, on tick-borne illnesses.

 

Communication toolkit on tick-borne diseases

This communication toolkit, developed by ECDC, includes template materials such as posters, leaflets, factsheets, etc. for different audiences with information on tick-borne diseases and preventive measures. The aim of the toolkit is to assist public health authorities in Member States in the development of strategies and communication materials to raise awareness on prevention and control of tick-borne diseases.

image

One of the ECDC toolkits available for download

 

And it isn’t just ticks.

 

The list of mosquito-borne diseases that could in the future (or already do) threaten parts of Europe includes West Nile Virus, Dengue, Malaria, Yellow Fever, Chikungunya, Zika Virus, Yellow Fever, Ockelbo virus, and even Rift Valley Fever.

In 2010 the journal Eurosurveillance devoted an entire issue to The Threat Of Vector Borne Diseases, with perhaps the biggest threat outlined in Yellow fever and dengue: a threat to Europe? by P Reiter.

 

For more on the mosquito-borne threat to Europe you may wish to revisit last April’s ECDC: Status & Importance Of Invasive Mosquito Breeds In Europe and from last year, ECDC: Local Malaria Acquisition In Greece.

 

And while less commonly known, Visceral Leishmaniasis (VL) is the most serious of the sandfly-borne diseases in Europe. While it rarely causes symptoms in healthy individuals - it can pose a deadly threat to those with HIV or compromised immune systems.

 

With these new maps the ECDC not only hopes to alert the public as to how to prevent vector borne illness but to track the changes in their geographic range over time.

 

All of this highlights the fact that you don’t have to travel thousands of miles to some exotic tropical clime in order to be exposed to Dengue, Malaria, Borreliosis, or West Nile Virus.

 

While still relatively rare in Europe (and North America, as well), these diseases continue to make inroads, and over time are likely to  increase as serious threats to public health.

»» Read More

ECDC: Status & Importance Of Invasive Mosquito Breeds In Europe

 

image



# 6365

 

While once thought of as something only a problem to tropical or semi-tropical regions, mosquito borne diseases like Malaria, Dengue, and Chikungunya increasingly pose a threat to parts of Europe as well.

 

A few recent examples:

 

  • Last year the CDC issued a travel announcement for Greece regarding a few cases of autochthonous P. Vivax malaria transmission that had been reported over the previous months (see ECDC: Local Malaria Acquisition In Greece).

 

 

  • In 2007, a traveler returning from India imported Chikungunya into Northern Italy, resulting in the infection of nearly 300 residents (for details see It's A Smaller World After All).

 

 

The list of mosquito-borne diseases that could in the future (or already do) threaten parts of Europe go beyond the three mentioned above, and includes West Nile Virus, Zika Virus, Yellow Fever, Ockelbo virus, and even Rift Valley Fever.

 

In 2010 the journal Eurosurveillance devoted an entire issue to The Threat Of Vector Borne Diseases, with perhaps the biggest threat outlined in Yellow fever and dengue: a threat to Europe? by P Reiter.

 

Complicating matters, as global climate change occurs, and as mosquito species are spread inadvertently through the movement of trade goods, ships, and airplanes, new – potentially invasive – mosquito species are being introduced into Europe.

 

Accordingly, it was announced last year that in 2012 the ECDC will produce guidelines to assist Member States in implementing invasive mosquito vector surveillance.

 

Today, as part of that ongoing process,  the ECDC has released a review of the public health ramifications of invasive mosquitoes in Europe.

 

 

Review of status and public health importance of invasive mosquitoes in Europe

30 Apr 2012

mosquito

ECDC

Invasive mosquito species in Europe present a potential public health threat and their surveillance and control are essential, concludes an article published this week in the journal ‘Vector-borne and zoonotic diseases’, funded and co-authored by ECDC.

 

The article provides a review of the current geographic spread (pathways for importation and onward dissemination), public health risks related to disease transmission, biology and climatic conditions and control methods of the invasive mosquitoes in Europe.

 

In the recent years six  non-European Aedes mosquitoes (Aedes albopictus, Aedes aegypti, Aedes japonicus, Aedes atropalpus, Aedes koreicus, Aedes triseriatus) have been imported in Europe through the international trade and some of these species are established and spread in Europe.

 

The invasive mosquito species present a public health risk, as they can be vectors for a number of pathogens. While there is no proof that they could all transmit diseases, there is a potential risk linked to the presence of such mosquito species in Europe, concludes the article. Recent outbreaks of mosquito-borne disease - the chikungunya fever in Italy in 2007 and subsequent autochthonous cases of dengue fever in France and Croatia in 2010 - confirms this threat . This risk can increase in the future, state the authors, due to geographical establishment of the mosquito species in Europe, more frequent travel, and more favourable climatic conditions.

 

That is why, surveillance and control of the exotic mosquito species in Europe are essential. ECDC through VBORNET (a network of European medical entomologists and public health experts) (link to VBORNET) generates updated quarterly maps of the current distribution status of the exotic mosquito species in Europe (link to maps) - based on a compilation of existing data from various sources. Information exchange between medical entomologists, public health professionals responsible for managing disease outbreaks and policymakers is needed to improve preparedness for vector-borne diseases.

 

ECDC will produce in 2012 guidelines to assist the Member States to implement invasive mosquito vector surveillance (link to Mosquito guidelines page) and improve coverage and harmonization of data collection within the EU.

 

Read the article – published in Vector-borne and zoonotic diseases and openly accessible:


A Review of the Invasive Mosquitoes in Europe: Ecology, Public Health Risks, and Control Options, Jolyon M. Medlock, Kayleigh M. Hansford, Francis Schaffner,  Veerle Versteirt, Guy Hendrickx, Herve Zeller, and Wim Van Bortel5, Vector-borne and zoonotic diseases, Volume 12, Number XX, 2012

Read more:
Aedes aegypti
Aedes albopictus
Aedes japonicus
Mosquito guidelines
Vector-borne diseases
Emerging and Vector-borne Diseases Programme

 

 

 

While today’s report focuses on Europe, the problem of new invasive mosquito species – and the spread of vector-borne diseases into new territories – is of global concern.


A few of my blogs on the threats to North America include:

 

EID Journal:Vector-Borne Infections
Florida: Locally Acquired Malaria Case Suspected
ASTMH: Dengue and Insect-Borne EIDs In The US
MMWR: Dengue Fever In Key West
Eastern Equine Encephalitis (EEE)
»» Read More

Preparing For An Unwanted Arrival

 

 

 


# 6177

 

 

PAHO, the Pan American Health Organization, in partnership with the CDC, have put together a 161-page guide for preparing for the arrival of Chikungunya to the Americas.

 

Chikungunya is a mosquito borne alphavirus (similar to Australia’s Ross River Virus, and EEE), of East African origin, that typically produces a fever, severe muscle and joint pain, and headaches.

 

They symptoms usually go away after a few weeks, but some patients can retain permanent disability.

 

First described in the early 1950s in Tanganyika, it was only sporadically seen over the years in eastern and central Africa. That is, until 2005, when Chikungunya made a jump to the Indian Ocean island of Réunion.

 

In the seven years since that time, Chik has migrated to India, Indonesia, and much of south-east Asia.   It has even been imported into Italy.

 

I told the story several years ago in It's A Smaller World After All, but the short version is that a traveler, returning from India, brought the virus to Italy in 2007 which led to more than 290 cases reported in the province of Ravenna, which is in northeast Italy.

 

image

 

Many infectious disease specialists have expressed concerns that Florida – which has recently seen a return of Dengue fever after more than 5 decades – could one day face the establishment of chikungunya as well.

 

The two primary mosquito vectors of Chikungunya are the Aedes aegypti and Aedes albopictus, both of which can be found across many regions of the Americas.

 

image

Aedes albopictus (Asian Tiger) Mosquito

Dark blue: Native range
Dark green: introduced (as of December 2007)

 

 image

Credit – PAHO

 

For more on all of this, excerpts from the press release from PAHO, and a link to the PDF.

 

PAHO, CDC publish guide on preparing for chikungunya virus Introduction in the Americas

 

The Pan American Health Organization/World Health Organization (PAHO/WHO), in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), has published new guidelines on chikungunya, a mosquito-transmitted virus transmitted that causes fever and severe joint pain.  The Guidelines for Preparedness and Response for Chikungunya Virus Introduction in the Americas aims to help countries throughout the Americas improve their ability to detect the virus and be prepared to monitor, prevent, and control the disease, should it appear.

 

Hundreds of people who have traveled from the Americas to Asia and Africa in the past five years have become infected with the chikungunya virus. While the virus has not spread locally in the Western Hemisphere, experts say there is a clear risk of its introduction into local mosquito populations. Local transmission could occur if mosquito populations in the United States or elsewhere in the Americas became infected with the virus and began spreading it to people in that area.

(Continue . . . )

 

To download the guide, Preparedness and Response for Chikungunya Virus Introduction in the Americas select this link.

»» Read More

Brave New Mosquito

 

 


# 5932

 

Image: Dengue in the world

Global Spread of Dengue

 

Dengue is a rapidly expanding mosquito-borne virus that is estimated to infect around 50 million people every year. Tens of thousands die annually, and as yet, there is no effective vaccine.

 

The explosive growth of Dengue around the world is well illustrated by the following graph from the World Health Organization.

 

Average annual number of dengue cases reported to the World Health Organization - has steadily increased since the 1950s, with 908 cases average reported between 1950 and 1959 and 968,564 cases average reported annually between 2000 and 2007.

What this graph doesn’t indicate is another doubling of dengue cases has taken place over the past 5 years


Nearly a year ago I wrote about the controversial release of genetically modified mosquitoes (see The Cayman Island Mosquito Trials) by the Oxitec company in a bid to learn how to reduce these Dengue vectors.

 


Oxitec’s genetically altered terminator mosquitoes have been bio-engineered to carry a lethal gene that the males can pass on to their progeny that causes them to die in the larval stage.

 

And the early results were very promising.

 

An 80% reduction of mosquitoes in a 25 acre test area after 19,000 males mosquitoes were released over a 4-week period in 2010.

 

Since this  research was conducted quietly, with little publicity, some public concern has since risen. The Cayman Island government produced this short video explaining the process in an attempt to allay any fears.

 

 

 

 

Oxitec has a short  FAQ page on their technology, which you can access here.

 

This research was published yesterday in the Nature Biotechnology journal.

 

Field performance of engineered male mosquitoes

Angela F Harris, Derric Nimmo, Andrew R McKemey,Nick Kelly, Sarah Scaife, Christl A Donnelly, Camilla Beech, William D Petrie & Luke Alphey

 

 

Yesterday the New York Times and The BBC both carried extensive stories on this research. Of the two, the NYT’s article adopted a bit more of a cautionary tone. 

 

Concerns Are Raised About Genetically Engineered Mosquitoes

By ANDREW POLLACK
Published: October 30, 2011

 

While the BBC article simply states that the World Health Organization is `cognizant that genetic engineering is a technology that carries the potential for risks as well as benefits’, and is working on guidelines.

 

GM mosquitoes show fever promise

By Richard Black  30 October 2011

 

Both articles provide useful background.

 

Oxitec’s GM process isn’t the only bid to modify mosquitoes to reduce disease transmission. 

 

Earlier this year in A Mosquito STD To Fight Dengue I wrote about a project to infect mosquitoes with Wolbachia, a bacteria commonly found in fruit flies that – for reasons that aren’t entirely clear - inhibits a mosquito’s ability to transmit Dengue Fever.

 

Around the beginning of the year scientists in Queensland, Australia began releasing thousands of Wolbachia infected mosquitoes each week into the remote communities of Gordonvale and Yorkeys Knob.

 

The hope being that infected mosquitoes would eventually supplant the uninfected native mosquito population.  Helping this project along is the way that Wolbachia is transmitted among mosquitoes. 

 

You see . . .  among mosquitoes, Wolbachia is essentially an STD, a sexually transmitted disease.

 

The bottom line:  Within a matter of a few months the Wolbachia infected mosquitoes overran the uninfected mosquito population in these two test environments.

 

While extremely encouraging, more tests are needed, including confirmation that this process works against all dengue serotypes. The Gates Foundation is providing further funding to support the release of Wolbachia mosquitoes in Australia, Vietnam and Thailand.

 

While there are safety issues that must be addressed - and getting the public to accept genetically modified  mozzies may be an issue - the creation of a Brave New Mosquito may someday contribute to the reduction of Dengue, Malaria, and other mosquito-borne diseases around the world.

 

At least, that’s the hope.

»» Read More